GMED
Globus MedicalDNYSE / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
The primary-company read is constructive: Q1 revenue rose 27.0%, base business ex-Nevro grew 13.2%, and full-year non-GAAP EPS guidance moved up to $4.70-$4.80 [#8-K-2026-05-07]. The stronger direct-peer frame is spine and orthopedics rather than generic medtech, which keeps the bull case tied to share gains, procedure volumes, and enabling-technology adoption.
Posture
Defensive
Lead driver
Value
What changed
1 setup hits (3d) with net bullish as of 2026-06-03.
What can break
Competition is a concrete execution risk: Globus named Medtronic, DePuy Synthes, Stryker, Zimmer Biomet, Smith + Nephew, Alphatec, Orthofix, Integra LifeSciences, ZimVie, VB Spine, Boston Scientific, and others as competitors in musculoskeletal disorders [#10-K-2026-02-24].
Momentum
24
Value
60
Sentiment
54
Setup hits (3d)
1 · Net Bullish
AI TargetsBase $92.00 · Bull $106.00 · Bear $74.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Bullish
Target $109.54
Why
Momentum24 · Δ7d -2.1
Value60 · Δ7d +0.5
Sentiment54 · Δ7d +10.2
So what
Weak posture (Net Bullish). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
24
34% active weight
Current posture
7d trendSoftening
Δ7d
-2.1
Δ21d
-14.3
Value
60
32% active weight
Current posture
7d trendFlat
Δ7d
+0.5
Δ21d
-0.8
Sentiment
54
33% active weight
Current posture
7d trendImproving
Δ7d
+10.2
Δ21d
+4.0
Why this grade
Composite grade D. Momentum 23.6 / Value 60.5 / Sentiment 53.9
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$10.62B
Beta
1.06
Shares Out
133.84M
P/E (TTM)
29.2
P/S (TTM)
4.37
P/FCF (TTM)
21.25
Rev YoY
+22.9%
EPS YoY
+134.0%
Gross Margin
+65.3%
Op Margin
+17.5%
Net Debt
-$446.18M
Current Ratio
4.13
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology